Skip to main content
Premium Trial:

Request an Annual Quote

Another Dot-com Shakeout? We Hope Not...

Via Wired, David Ewing Duncan writes for Portfolio.com about the direct-to-consumer personal genetics market, and how this has caught regulatory bodies and health care providers off guard. With the passage of GINA and an advisory committee at the Department of Health and Human Services advocating for tighter regulation of consumer genetic tests, the vetting has begun. "We welcome responsible regulation," says David Agus, co-founder of Navigenics. "There needs to be medical standards and a system for validating this information."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.